Clinical evidence and research

The Low Carb Program is built upon a robust evidence-base and supported by peer-reviewed clinical health and engagement outcomes


Peer-reviewed one-year health outcomes

We’re conducting a three year study following 1,000 people with type 2 diabetes who enrolled on the platform. One-year peer-reviewed, published health outcomes demonstrate the platform is effective for glycemic control, weight loss, and reducing hypoglycemic medications.

7.4 kilograms

average weight loss

1.2% / 13mmol/mol

average HbA1c reduction

39% of patients

reduce their HbA1c under type 2 diagnosis threshold

40% of patients

on medication eliminate at least one of them

60% of patients

on insulin eliminate or reduce the medication

1 in 4 patients

put type 2 diabetes into remission

Weight loss

At the one-year follow-up, participants who had completed the Low Carb Program achieved a significant average weight loss; the average weight loss from baseline to one year was 7.4kg, or 7% of body weight.

weight-icon 7%

Mean body weight loss



Members who complete the Low Carb Program significantly reduce HbA1c by an average of 1.2% (13 mmol/mol).

hba1c-icon 13 mmol/mol

(1.2%) HbA1c reduction



Members experienced significant reduction and elimination of medications from baseline to follow-up.

The bar chart below represents percentage of users who have reduced or eliminated at least one diabetes medication.

medication-icon 54%

of patients eliminate or reduce diabetes medication


How does it compare to standard care at one year?

The Low Carb Program provides a sustainable approach to weight loss and blood glucose management.

Low Carb Program Standard Care
Weight ⬇︎ 7.4kg -
HbA1c ⬇︎ 1.2% ⬆︎ 0.2%
Medication* ⬇︎ 54% ⬆︎ 9%
Remission ⬆︎ 26% ⬆︎ 0.1%

* Diabetes medicines, excluding Metformin

Saslow LR, Summers C, Aikens JE, Unwin DJ Outcomes of a Digitally Delivered Low-Carbohydrate Type 2 Diabetes Self-Management Program: 1-Year Results of a Single-Arm Longitudinal Study, JMIR Diabetes. doi:10.2196/diabetes.9333

Hallberg et al. Effectiveness and Safety of a Novel Care Model for the Management of Type 2 Diabetes at 1 Year. Diabetes Ther. Doi: 10.1007/s13300-018-0373-9

Advancing the evidence base

The Low Carb Program is innovating in both digital health and nutrition. As a result, the Low Carb Program is involved in a number of research studies with health and academic institutions across the globe.

Published outcomes demonstrate that the Low Carb Program is a scalable, effective and engaging solution for type 2 diabetes and prediabetes remission.

Peer-reviewed outcomes


Low Carb Program: One Year Health Outcomes

The Low Carb Program’s one-year health outcomes followed 1,000 people and demonstrated an online program that teaches a carbohydrate-reduced diet to adults with type 2 diabetes can be effective for glycemic control, weight loss, and reducing hypoglycemic medications.

Independent research


Symphony Healthcare Services: Scaling Type 2 Remission

The Low Carb Program partnered with Symphony Healthcare Services in Wincanton, Somerset to achieve 50 cases of type 2 diabetes remission. At 3 months, there is a 97% platform enrolment, 86% completion and 8.1% body weight loss.

Ongoing research


University of British Columbia: Usability study

The Low Carb Program has partnered with the Diabetes Prevention Research Group to evaluate the barriers and facilitators to engaging in the Low Carb Program and making dietary changes both within the time-period of the program and for a year follow-up.